BeOne Medicines (ONC) News Today $338.92 +4.52 (+1.35%) As of 12:56 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period BeOne Medicines (NASDAQ:ONC) Upgraded to "Strong-Buy" at Zacks ResearchSeptember 21 at 9:52 AM | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of "Buy" from AnalystsSeptember 21 at 4:11 AM | marketbeat.com828 Shares in BeOne Medicines Ltd. - Sponsored ADR $ONC Acquired by Aaron Wealth Advisors LLCSeptember 20 at 3:52 AM | marketbeat.comBarclays Begins Coverage on BeOne Medicines (NASDAQ:ONC)September 20 at 3:29 AM | americanbankingnews.comBeOne Medicines (NASDAQ:ONC) CEO Sells $9,055,715.13 in StockSeptember 19 at 5:31 PM | marketbeat.comBeOne Medicines (NASDAQ:ONC) Now Covered by BarclaysSeptember 19 at 8:32 AM | marketbeat.comJohn Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) StockSeptember 19 at 6:38 AM | insidertrades.comBarclays Initiates Coverage of BeOne Medicines AG - Depositary Receipt (ONC) with Overweight RecommendationSeptember 18, 2025 | msn.comBeOne Medicines initiated with an Overweight at BarclaysSeptember 18, 2025 | msn.comInsider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 10,006 Shares of StockSeptember 14, 2025 | marketbeat.comCitizens JMP Maintains a Buy Rating on BeOne Medicines (ONC)September 14, 2025 | msn.comInsider Selling: BeOne Medicines (NASDAQ:ONC) Insider Sells 5,000 Shares of StockSeptember 13, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - Still a Buy?September 13, 2025 | marketbeat.comChan Henry Lee Sells 10,006 Shares of BeOne Medicines (NASDAQ:ONC) StockSeptember 13, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down on Insider SellingSeptember 12, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Director Sells $898,105.00 in StockSeptember 11, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider SellingSeptember 11, 2025 | americanbankingnews.comWhite House mulls restrictions on medicines invented in China: NYTSeptember 10, 2025 | msn.comChina-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive OrderSeptember 10, 2025 | msn.comPharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.September 10, 2025 | finance.yahoo.comBeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High - Still a Buy?September 10, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Director Corazon (Corsee) Sanders Sells 2,665 SharesSeptember 10, 2025 | insidertrades.comBeOne Medicines AG (ONC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comBeOne Medicines (NASDAQ:ONC) Insider Sells 122 SharesSeptember 5, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Reaches New 52-Week High - Here's WhySeptember 4, 2025 | marketbeat.comStocks Showing Market Leadership: BeOne Medicines ADR Earns 92 RS RatingSeptember 3, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - Here's WhyAugust 31, 2025 | marketbeat.comBeOne Medicines stock rises after positive Phase 1/2 resultsAugust 30, 2025 | za.investing.comBeOne Medicines stock rises after positive Phase 1/2 resultsAugust 30, 2025 | in.investing.comBeOne Medicines succeeds in Phase 1/2 study for lymphoma therapyAugust 30, 2025 | msn.comBeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)August 29, 2025 | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Average Recommendation of "Buy" from AnalystsAugust 29, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Average Rating of "Buy" from AnalystsAugust 29, 2025 | marketbeat.comBeOne Medicines announces EC approved Tevimbra to treat NSCLCAugust 28, 2025 | msn.comWith 42% institutional ownership, BeOne Medicines Ltd. (NASDAQ:ONC) is a favorite amongst the big gunsAugust 28, 2025 | finance.yahoo.comBeOne Medicines shares dip after EU greenlights TEVIMBRA for lung cancerAugust 27, 2025 | msn.comBeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 26, 2025 | businesswire.comBeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-UpAugust 25, 2025 | finance.yahoo.comRoyalty Pharma confirms acquisition of royalty interest in Amgen’s ImdelltraAugust 25, 2025 | msn.comBeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950MAugust 25, 2025 | msn.comBRUKINSA Tablet Approval Could Be a Game Changer for BeOne Medicines (ONC)August 22, 2025 | finance.yahoo.comBeOne Medicines’ Brukinsa tablet formulation approved by European CommissionAugust 21, 2025 | msn.comEuropean Commission Approves Tablet Formulation of BeOne Medicines' BRUKINSA® for All Approved IndicationsAugust 21, 2025 | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells $3,308,855.85 in StockAugust 17, 2025 | marketbeat.comXiaobin Wu Sells 39,936 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockAugust 17, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Xiaobin Wu Sells 49,858 SharesAugust 17, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High - Time to Buy?August 17, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells 11,013 Shares of StockAugust 16, 2025 | insidertrades.comThis Medical Stock With Blockbuster Cancer Drug Clears Entry Amid 923% Earnings GrowthAugust 15, 2025 | investors.comStock Market Today: Dow Jones Index Rises While Nvidia-Backed CoreWeave Sinks On Earnings (Live Coverage)August 13, 2025 | msn.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.590.73▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼127▲ONC Articles Average Week Get the Latest News and Ratings for ONC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BeOne Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SNY News GSK News TAK News ARGX News INSM News BNTX News TEVA News GMAB News SMMT News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts